Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer
Clinical trial NCT00191243 · COMPLETED
Trial details
- NCT number
- NCT00191243
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2007-08-01
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.